Cargando…
Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370228/ https://www.ncbi.nlm.nih.gov/pubmed/32555451 http://dx.doi.org/10.1038/s41418-020-0576-2 |
| _version_ | 1783560949739814912 |
|---|---|
| author | Thijssen, Rachel Alvarez-Diaz, Silvia Grace, Clea Gao, Ming-yuan Segal, David H. Xu, Zhen Strasser, Andreas Huang, David C. S. |
| author_facet | Thijssen, Rachel Alvarez-Diaz, Silvia Grace, Clea Gao, Ming-yuan Segal, David H. Xu, Zhen Strasser, Andreas Huang, David C. S. |
| author_sort | Thijssen, Rachel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7370228 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73702282020-07-24 Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells Thijssen, Rachel Alvarez-Diaz, Silvia Grace, Clea Gao, Ming-yuan Segal, David H. Xu, Zhen Strasser, Andreas Huang, David C. S. Cell Death Differ Comment Nature Publishing Group UK 2020-06-18 2020-08 /pmc/articles/PMC7370228/ /pubmed/32555451 http://dx.doi.org/10.1038/s41418-020-0576-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Comment Thijssen, Rachel Alvarez-Diaz, Silvia Grace, Clea Gao, Ming-yuan Segal, David H. Xu, Zhen Strasser, Andreas Huang, David C. S. Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells |
| title | Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells |
| title_full | Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells |
| title_fullStr | Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells |
| title_full_unstemmed | Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells |
| title_short | Loss of RIPK3 does not impact MYC-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells |
| title_sort | loss of ripk3 does not impact myc-driven lymphomagenesis or chemotherapeutic drug-induced killing of malignant lymphoma cells |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370228/ https://www.ncbi.nlm.nih.gov/pubmed/32555451 http://dx.doi.org/10.1038/s41418-020-0576-2 |
| work_keys_str_mv | AT thijssenrachel lossofripk3doesnotimpactmycdrivenlymphomagenesisorchemotherapeuticdruginducedkillingofmalignantlymphomacells AT alvarezdiazsilvia lossofripk3doesnotimpactmycdrivenlymphomagenesisorchemotherapeuticdruginducedkillingofmalignantlymphomacells AT graceclea lossofripk3doesnotimpactmycdrivenlymphomagenesisorchemotherapeuticdruginducedkillingofmalignantlymphomacells AT gaomingyuan lossofripk3doesnotimpactmycdrivenlymphomagenesisorchemotherapeuticdruginducedkillingofmalignantlymphomacells AT segaldavidh lossofripk3doesnotimpactmycdrivenlymphomagenesisorchemotherapeuticdruginducedkillingofmalignantlymphomacells AT xuzhen lossofripk3doesnotimpactmycdrivenlymphomagenesisorchemotherapeuticdruginducedkillingofmalignantlymphomacells AT strasserandreas lossofripk3doesnotimpactmycdrivenlymphomagenesisorchemotherapeuticdruginducedkillingofmalignantlymphomacells AT huangdavidcs lossofripk3doesnotimpactmycdrivenlymphomagenesisorchemotherapeuticdruginducedkillingofmalignantlymphomacells |